Valuation: Vivos Therapeutics, Inc.

Market Cap 1.65M 1.5M 1.39M 1.25M 2.36M 155M 2.46M 16.71M 6.62M 83.36M 6.2M 6.07M 264M P/E 2026 *
-0.06x
P/E 2027 * -0.1x
Enterprise Value 1.65M 1.5M 1.39M 1.25M 2.36M 155M 2.46M 16.71M 6.62M 83.36M 6.2M 6.07M 264M EV / Sales 2026 *
0.08x
EV / Sales 2027 * 0.05x
Free-Float
87.96%
Yield 2026 *
-
Yield 2027 * -
1 day-3.04%
1 week-16.81%
Current month-29.96%
1 month-39.21%
3 months-76.78%
6 months-87.57%
Current year-96.07%
1 week 0.07
Extreme 0.0709
0.1
1 month 0.07
Extreme 0.0709
0.14
Current year 0.07
Extreme 0.0709
2.69
1 year 0.07
Extreme 0.0709
2.69
3 years 0.07
Extreme 0.0709
48.79
5 years 0.07
Extreme 0.0709
92.25
10 years 0.07
Extreme 0.0709
360.25
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer - -
Chief Operating Officer - 01/09/2016
Chief Executive Officer 68 01/09/2016
Director TitleAgeSince
Chairman 68 01/06/2020
Director/Board Member 86 01/06/2020
Director/Board Member 58 01/06/2020
Date Insider Type Main position Quantity % Market Cap. Importance
9/14/26 A Other

Director

12,000 0.0596%
9/14/26 A Free

Director

12,000 0.0596%
7/31/26 A Free

Chief Financial Officer

400,000 2.8788%
Change 5-day change 1-year change 3-year change Capi.($)
-3.04%-16.81%-96.59%-97.95% 1.65M
-2.55%-5.25%-19.82%+4.44% 186B
-0.54%-0.46%+6.73%+36.65% 126B
+2.19%-2.51%-12.34%+8.91% 118B
-3.09%-6.19%-43.93%+0.52% 93.33B
-1.79%+1.39%-3.14%+78.03% 68.11B
-0.49%+0.08%+11.59%-8.36% 58.96B
-1.49%-2.32%+0.04%+47.92% 55.2B
-0.45%+0.41%-3.74%+42.17% 48.58B
-0.55%+0.95%+0.16%-0.74% 35.56B
Average -1.18%-1.50%-16.10%+11.16% 79B
Weighted average by Cap. -1.07%-0.94%-10.26%+20.29%

Financials

2026 *2027 *
Net sales 21.79M 19.81M 18.32M 16.5M 31.14M 2.04B 32.35M 220M 87.17M 1.1B 81.74M 80.02M 3.47B 34.09M 31M 28.65M 25.81M 48.72M 3.19B 50.61M 345M 136M 1.72B 128M 125M 5.43B
Net income -23.84M -21.68M -20.04M -18.05M -34.07M -2.23B -35.4M -241M -95.38M -1.2B -89.44M -87.55M -3.8B -14.7M -13.37M -12.36M -11.13M -21.01M -1.37B -21.83M -149M -58.83M -741M -55.16M -54M -2.34B
Net Debt - -
Projected Income Statement - Annual - Vivos Therapeutics, Inc.
Logo Vivos Therapeutics, Inc.
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods that promote sleep wellness and health for patients suffering from breathing and sleep issues such as obstructive sleep apnea (OSA) and snoring in adults. The Company's Complete Airway Repositioning and/or Expansion (CARE) devices are the oral appliances cleared by the United States Food and Drug Administration (FDA) for adult patients diagnosed with all severity levels of OSA (including severe OSA) and moderate-to-severe OSA in children ages 6 to 17 within the FDA cleared usage for such devices. The Company's products and services include Vivos CARE oral appliance therapy, Vivos oral appliances and therapies outside of CARE system, Vivos AireO2, Adjunctive Treatment, Treatment Navigator, Vivos Billing Intelligence Service (BIS) and Vivos Airway Intelligence Service, and others. The Company has sleep testing centers and associated medical sleep practice.
Employees
268
Date Price Change Volume
17/11/26 $0.0800 -2.68% 866,357
16/11/26 $0.0822 -16.12% 5,402,519
13/11/26 $0.0980 +2.40% 793,837
12/11/26 $0.0957 +5.75% 508,554
11/11/26 $0.0905 +4.87% 595,555
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Vivos Therapeutics, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
0.0822USD
Average target price
1.925USD
Spread / Average Target
+2,241.85%
  1. Stock Market
  2. Stocks
  3. VVOS Stock